Rheumatology Doctors in West Lake Hills, TX Accepting Medicare

4 Rheumatology doctors found. Showing 1 - 4

Eduardo J. Cepeda, M.D. Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 4701 Bee Caves Rd Ste 201, West Lake Hills, TX 78746 Phone: 512-518-4992    Fax: 512-901-3918

Christopher T. R. Parker, DO Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 4701 Bee Caves Rd Ste 201, West Lake Hills, TX 78746 Phone: 512-518-4992    Fax: 866-298-0735

Monty B. Tew, MD Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 4701 Bee Caves Rd Ste 201, West Lake Hills, TX 78746 Phone: 512-518-4992

Kevin Glen Osgood, MD Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 4701 Bee Caves Rd Ste 201, West Lake Hills, TX 78746 Phone: 512-518-4992    Fax: 866-298-0735

News Archive

Energy/Sports drinks damage teeth enamel raising risk of cavities: Study

Researcher Poonam Jain, associate professor and director of community dentistry at the Southern Illinois University School of Dental Medicine said, "The big misconception is that energy drinks and sports drinks are healthier than soda for oral health. This study completely disproves that, because they erode or thin out the enamel of the teeth, leaving them more susceptible to decay and sensitivity."

Health Care REIT reports $292.9M of gross investments during second-quarter 2010

Health Care REIT, Inc. announced today that it completed $292.9 million of gross investments during the second quarter of 2010. During the quarter, the company had dispositions of $14.6 million, resulting in net new investments of $278.3 million. For the six months ended June 30, 2010, the company completed $877.6 million of gross investments, offset by $47.5 million of asset sales and loan payoffs, which generated $830.1 million of net new investments.

Arcion receives U.S. patent allowance for ARC-2022 to treat PHN

Arcion Therapeutics, a clinical stage biotechnology company developing topical therapies for chronic pain, today announced that it received notice of allowance for a US Patent for its high strength gel formulation of topical lidocaine, ARC-2022.

Allergan announces U.S. availability of SAPHRIS 2.5 mg tablets for children with bipolar I disorder

Allergan plc today announced that SAPHRIS (asenapine) 2.5 mg sublingual (placed under the tongue) black-cherry flavored tablets are available in pharmacies throughout the U.S. In March 2015, the U.S. Food and Drug Administration approved SAPHRIS for the acute treatment of manic or mixed episodes associated with bipolar I disorder in pediatric patients (ages 10 – 17).

Vitamin D and Diabetes: What You Need To Know

Dr. Cedric Garland discusses the results of a 12-year cohort study which showed that vitamin D3 can prevent type 1 diabetes in 80 percent of cases.

Read more Medical News

› Verified 4 days ago